# EDGAR Filing Document

**Accession Number:** 0001553254
**File Stem:** 0001209191-23-016370
**Filing Date:** 2023-3
**Character Count:** 12155
**Document Hash:** 9cca4118d98c7fc5572c3ac21e7a490d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209191-23-016370.hdr.sgml**: 20230306

**ACCESSION NUMBER**: 0001209191-23-016370

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230302

**FILED AS OF DATE**: 20230306

**DATE AS OF CHANGE**: 20230306

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Maltz Jules A.
- **CENTRAL INDEX KEY:** 0001553254

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38986
- **FILM NUMBER:** 23709747

**MAIL ADDRESS:**
- **STREET 1:** 3000 SAND HILL ROAD
- **STREET 2:** BUILDING 2, SUITE 250
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94025
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hims & Hers Health, Inc.
- **CENTRAL INDEX KEY:** 0001773751
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2269 CHESTNUT ST
- **STREET 2:** #523
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94123
- **BUSINESS PHONE:** 415-851-0195

**MAIL ADDRESS:**
- **STREET 1:** 2269 CHESTNUT ST
- **STREET 2:** #523
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94123

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Oaktree Acquisition Corp.
- **DATE OF NAME CHANGE:** 20190412

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Maltz Jules A.<br><sub>(Last) (First) (Middle)</sub><br>3000 SAND HILL ROAD BLDG. 2, SUITE 250<br><sub>(Street)</sub><br>MENLO PARK, CA 94025<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-02 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hims & Hers Health, Inc. [ HIMS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 2023-03-02 |  | J<sup>(1)</sup> |  | 2486770 | D | $0.00 | 7668334<sup>(2)</sup> | I | By Institutional Venture Partners XV, L.P.<sup>(3)</sup> |
| Class A Common Stock | 2023-03-02 |  | J<sup>(4)</sup> |  | 13188 | D | $0.00 | 40786 | I | By Institutional Venture Partners XV Executive Fund, L.P.<sup>(5)</sup> |
| Class A Common Stock | 2023-03-02 |  | J<sup>(6)</sup> |  | 2500000 | D | $0.00 | 7709091<sup>(7)</sup> | I | By Institutional Venture Partners XVI, L.P.<sup>(8)</sup> |
| Class A Common Stock | 2023-03-02 |  | J<sup>(9)</sup> |  | 537143 | A | $0.00 | 537143<sup>(2)</sup> | I | By Institutional Venture Management XV, LLC<sup>(10)</sup> |
| Class A Common Stock | 2023-03-02 |  | J<sup>(11)</sup> |  | 537143 | D | $0.00 | 0 | I | By Institutional Venture Management XV, LLC<sup>(10)</sup> |
| Class A Common Stock | 2023-03-02 |  | J<sup>(12)</sup> |  | 33180 | A | $0.00 | 33180 | I | By IVP Executive Fund XVI, LLC<sup>(13)</sup> |
| Class A Common Stock | 2023-03-02 |  | J<sup>(12)</sup> |  | 62500 | A | $0.00 | 62500<sup>(7)</sup> | I | By Institutional Venture Management XVI, LLC<sup>(14)</sup> |
| Class A Common Stock | 2023-03-02 |  | J<sup>(15)</sup> |  | 62500 | D | $0.00 | 0 | I | By Institutional Venture Management XVI, LLC<sup>(14)</sup> |
| Class A Common Stock | 2023-03-02 |  | J<sup>(16)</sup> |  | 95401 | A | $0.00 | 220401 | I | By Jules Maltz and Kelly Greenwood Fam Tr UA 07/31/2018 |
| Class A Common Stock | 2023-03-02 |  | S |  | 1789 | D | 10.10<sup>(17)</sup> | 7666545 | I | By Institutional Venture Partners XV, L.P.<sup>(3)</sup> |
| Class A Common Stock | 2023-03-02 |  | S |  | 51 | D | 10.10<sup>(17)</sup> | 40735 | I | By Institutional Venture Partners XV Executive Fund, L.P.<sup>(5)</sup> |
| Class A Common Stock | 2023-03-02 |  | S |  | 1800 | D | 10.10<sup>(17)</sup> | 7707291 | I | By Institutional Venture Partners XVI, L.P.<sup>(8)</sup> |
| Class A Common Stock | 2023-03-02 |  | S |  | 33180 | D | 10.10<sup>(17)</sup> | 0 | I | By IVP Executive Fund XVI, LLC<sup>(13)</sup> |
| Class A Common Stock |  |  |  |  |  |  |  | 20863 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XV, L.P. ("IVP XV") to its general partner and limited partners without additional consideration.

(2) The shares held by Institutional Venture Management XV, LLC ("IVM XV") prior to the transactions reported herein reflect the transfer of shares from IVM XV to IVP XV, which shares were previously held by IVM XV for the benefit of IVP XV and such transfer did not constitute a change in beneficial ownership.

(3) Shares are held by IVP XV. IVM XV is the sole general partner of IVP XV. The Reporting Person is a managing director of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV. The Reporting Person disclaims beneficial ownership of the shares held by IVP XV except to the extent of his pecuniary interest therein.

(4) Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV EF") to its limited partners without additional consideration.

(5) Shares are held by IVP XV EF. IVM XV is the sole general partner of IVP XV EF. The Reporting Person is a managing director of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV EF. The Reporting Person disclaims beneficial ownership of the shares held by IVP XV EF except to the extent of his pecuniary interest therein.

(6) Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XVI, L.P. ("IVP XVI") to its general partner and limited partners without additional consideration.

(7) The shares held by Institutional Venture Management XVI, LLC ("IVM XVI") prior to the transactions reported herein reflect the transfer of shares from IVM XVI to IVP XVI, which shares were previously held by IVM XVI for the benefit of IVP XVI and such transfer did not constitute a change in beneficial ownership.

(8) Shares are held by IVP XVI. IVM XVI is the sole general partner of IVP XVI. The Reporting Person is a managing director of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVP XVI. The Reporting Person disclaims beneficial ownership of the shares held by IVP XVI except to the extent of his pecuniary interest therein.

(9) Represents receipt of shares in the distribution in kind described in footnote (1).

(10) Shares are held by IVM XV. The Reporting Person is a managing director of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVM XV. The Reporting Person disclaims beneficial ownership of the shares held by IVM XV except to the extent of his pecuniary interest therein.

(11) Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by IVM XV to its members without additional consideration.

(12) Represents receipt of shares in the distribution in kind described in footnote (6).

(13) Shares are held by IVP Executive Fund XVI, LLC ("IVP XVI EF"). IVM XVI is the manager of IVP XVI EF. The Reporting Person is a managing director of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVP XVI EF. The Reporting Person disclaims beneficial ownership of the shares held by IVP XVI EF except to the extent of his pecuniary interest therein.

(14) Shares are held by IVM XVI. The Reporting Person is a managing director of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVM XVI. The Reporting Person disclaims beneficial ownership of the shares held by IVM XVI except to the extent of his pecuniary interest therein.

(15) Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by IVM XVI to its members without additional consideration.

(16) Represents receipt of shares in the distributions in kind described in footnotes (11) and (15).

(17) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.01 to $10.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

**Signature:** Jules A. Maltz, By /s/ Tracy Hogan, Attorney-In-Fact  
**Date:** 2023-03-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**